Razor Pitch
  • Home
  • Sponsored Articles
  • Investor Testing
  • Blog
  • Contact
Select Page
Pfizer Inc. (NYSE:PFE) In Discussions To Supply South Africa COVID-19 vaccine At $10 Per Dose

Pfizer Inc. (NYSE:PFE) In Discussions To Supply South Africa COVID-19 vaccine At $10 Per Dose

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) have announced that they will offer South Africa discounted COVID-19 vaccine at $10 per dose. But according to sources familiar with the matter, the president has described the costs to be prohibitive. Vaccine dose...
Crypto.com Receives Australian Finance Service Licence To Issue Its Debit Card To Australian Residents

Crypto.com Receives Australian Finance Service Licence To Issue Its Debit Card To Australian Residents

Digital currency exchange and debit card provider, Crypto.com has announced securing an Australian Finance Service License (AFSL) to issue a debit card to Australian customers. The Australian Foreign Investment Review Board gave the Hong-Kong based exchange approval...
Pfizer Inc. (NYSE:PFE) In Discussions With Federal Government Of Brazil for Supply Of Its COVID-19 Vaccine

Pfizer Inc. (NYSE:PFE) In Discussions With Federal Government Of Brazil for Supply Of Its COVID-19 Vaccine

Pfizer Inc. (NYSE:PFE) has engaged the Brazilian Government to supply its investigational COVID-19 vaccine to the country in Q1 2021. Brazil’s Ministry of Health indicated in a statement on Tuesday that the country was planning to order the Pfizer vaccines once...
Pfizer Inc. (NYSE:PFE) And BioNTech SE (NASDAQ:BNTX) Commence COVID-19 Vaccine Trial In Japan

Pfizer Inc. (NYSE:PFE) And BioNTech SE (NASDAQ:BNTX) Commence COVID-19 Vaccine Trial In Japan

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) has announced the commencement of combined Phase I & II clinical study of their mRNA COVID-19 vaccine candidate in Japan. Pfizer to enroll 160 participants in a trial in Japan According to a statement from the...
Gilead Sciences (NASDAQ:GILD) Signs $1.2 billion Six-Month Joint Procurement Deal For Remdsivir With EU States

Gilead Sciences (NASDAQ:GILD) Signs $1.2 billion Six-Month Joint Procurement Deal For Remdsivir With EU States

The European Union has signed a procurement deal with Gilead Sciences (NASDAQ:GILD) for its COVID-19 drug. The EU will pay the company $1.2 billion for a six-month supply of the antiviral drug remdesivir before the publication of the results from the trial on the...
Johnson and Johnson (NYSE:JNJ) Signs Advance Purchase Agreement With The European Commission For Its COVID-19 Vaccine

Johnson and Johnson (NYSE:JNJ) Signs Advance Purchase Agreement With The European Commission For Its COVID-19 Vaccine

Johnson and Johnson (NYSE:JNJ) has announced that the European Commission has approved a supply agreement on behalf of EU members states for the supply of 400 million doses of COVID-19 vaccine. EC to purchase 400 million doses of JNJ’s vaccine According to the Advance...
« Older Entries
Next Entries »

Sample Banner Ads Below Drive Investor Traffic:

RazorPitch Inc.
9215 Belleza Way #204
Fort Myers, Florida 33908

  • Follow
  • Follow
  • Follow
  • Follow

Company

Home

Sponsored Articles

Investor Testing

Blog

 

 

Get Help

Contact

© 2006-2025 Razorpitch. All Rights Reserved.